Thomas K. Equels, CEO & President at AIM ImmunoTech Inc. (AIM), bought 322,582 shares at $0.31 ($100K) on 2023-01-03, disclosed to the SEC on 2023-01-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.31 | 161,291 | $50K | 50.0% |
| 2 | $0.31 | 161,291 | $50K | 50.0% |
| Total | $0.31 avg | 322,582 | $100K | 100% |
| Filing → |
| AIM | BUY | 2026-09-16 | $5K | — | Filing → |
| AIM | BUY | 2026-09-15 | $1K | — | Filing → |
| AIM | BUY | 2025-06-16 | $824 | — | Filing → |